JP2007518815A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518815A5
JP2007518815A5 JP2006551327A JP2006551327A JP2007518815A5 JP 2007518815 A5 JP2007518815 A5 JP 2007518815A5 JP 2006551327 A JP2006551327 A JP 2006551327A JP 2006551327 A JP2006551327 A JP 2006551327A JP 2007518815 A5 JP2007518815 A5 JP 2007518815A5
Authority
JP
Japan
Prior art keywords
composition
tenofovir
treating
dehobiru
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006551327A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002043 external-priority patent/WO2005072748A1/en
Publication of JP2007518815A publication Critical patent/JP2007518815A/ja
Publication of JP2007518815A5 publication Critical patent/JP2007518815A5/ja
Pending legal-status Critical Current

Links

JP2006551327A 2004-01-21 2005-01-21 乳癌および原発性胆汁性肝硬変に関与するmmtv様ウイルスを阻害するためのアデホビルまたはテノホビルの使用 Pending JP2007518815A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53806604P 2004-01-21 2004-01-21
PCT/US2005/002043 WO2005072748A1 (en) 2004-01-21 2005-01-21 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Publications (2)

Publication Number Publication Date
JP2007518815A JP2007518815A (ja) 2007-07-12
JP2007518815A5 true JP2007518815A5 (https=) 2008-03-13

Family

ID=34825960

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551327A Pending JP2007518815A (ja) 2004-01-21 2005-01-21 乳癌および原発性胆汁性肝硬変に関与するmmtv様ウイルスを阻害するためのアデホビルまたはテノホビルの使用

Country Status (10)

Country Link
US (2) US20070281911A1 (https=)
EP (1) EP1732569B1 (https=)
JP (1) JP2007518815A (https=)
AT (1) ATE445404T1 (https=)
AU (1) AU2005209256B2 (https=)
CA (1) CA2553455A1 (https=)
DE (1) DE602005017131D1 (https=)
ES (1) ES2334149T3 (https=)
NZ (1) NZ548532A (https=)
WO (1) WO2005072748A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114065A2 (en) * 2005-04-25 2006-11-02 Institute Of Organic Chemistry And Biochemistry A Cademy Of Sciences Of The Czech Republic Use of compounds to inhibit neoplasia
RU2301088C2 (ru) * 2005-09-01 2007-06-20 Ростовский научно-исследовательский онкологический институт МЗ РФ Способ лечения рецидива рака молочной железы
SI2020996T1 (sl) 2006-05-16 2012-03-30 Gilead Sciences Inc Postopek in sestavki za zdravljenje hematološkihmalignosti
WO2011044125A1 (en) * 2009-10-05 2011-04-14 Ambergen, Inc. A method for diagnosing primary biliary cirrhosis (pbc) using novel autoantigens
EP2625292B1 (en) 2010-10-07 2018-12-05 The General Hospital Corporation Biomarkers of cancer
ES3018133T3 (en) 2011-11-30 2025-05-14 Univ Emory Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae
EP3161159B1 (en) 2014-06-25 2020-08-05 The General Hospital Corporation Targeting human satellite ii (hsatii)
JP7381190B2 (ja) 2014-12-26 2023-11-15 エモリー・ユニバーシテイ N4-ヒドロキシシチジン及び誘導体並びにそれに関連する抗ウイルス用途
GB201509431D0 (en) * 2015-06-01 2015-07-15 Equigerminal Sa Antiviral composition
PT3706762T (pt) 2017-12-07 2024-12-05 Univ Emory N4-hidroxicitidina e derivados e utilizações antivirais relacionadas com os mesmos
KR102196711B1 (ko) * 2018-08-30 2020-12-30 가톨릭대학교 산학협력단 테노포비르 디소프록실 푸마르산을 유효성분으로 함유하는, 간섬유증 예방 또는 치료용 약학적 조성물
US20220143050A1 (en) * 2019-02-22 2022-05-12 Kazumoto Murata mTOR Inhibitor
WO2021003421A1 (en) * 2019-07-02 2021-01-07 Virago Vax Inc. Mammary tumor virus suppression
US12016844B2 (en) 2019-07-02 2024-06-25 Virago Vax Inc. Mammary tumor virus suppression
US12029783B2 (en) 2019-07-02 2024-07-09 Virago Vax Inc. Mammary tumor virus vaccine
IL315480A (en) 2022-03-15 2024-11-01 Rome Therapeutics Inc Compounds and methods for treating disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60038889D1 (de) * 1999-06-01 2008-06-26 Ochsner Med Found Alton Identifizierung eines neuartigen retrovirus welcher mit primärer leberzirrhose sowie autoimmunerkrankungen einhergeht
EP1190055B1 (en) * 1999-06-30 2008-06-25 The Administrators Of The Tulane Educational Fund Human endogenous retrovirus
US20020119443A1 (en) * 2000-07-21 2002-08-29 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
EP2223927B1 (en) * 2002-05-13 2014-10-15 Metabasis Therapeutics, Inc. Salts of a phosphonic acid based prodrug of PMEA

Similar Documents

Publication Publication Date Title
JP2007518815A5 (https=)
JP5763834B2 (ja) 置換2,3−ジヒドロイミダゾ[1,2−c]キナゾリン塩類
Douillard et al. Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation
ES2609767T3 (es) Combinaciones de un inhibidor de PI3K y un inhibidor de MEK
CY1119865T1 (el) Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου του παρκινσον
JP2008530108A5 (https=)
WO2013077921A9 (en) Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
JP2016006096A5 (https=)
JP2013516442A5 (https=)
JP2011529919A5 (https=)
WO2019236631A1 (en) Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses
JP2015536986A5 (https=)
JP2013224953A5 (https=)
JP2015502926A5 (https=)
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
JP2016514727A5 (https=)
RU2015139225A (ru) Применение производных, содержащих связи с-о-р, у пациентов с почечной недостаточностью
JP2019501185A (ja) 食道癌を治療するためのキノリン誘導体の使用とその治療方法、医薬組成物及びキット
JP2020531463A5 (https=)
JP2015117185A5 (https=)
RU2013154355A (ru) Способ лечения мезотелиомы ингибитором рi3к
JP2013511526A5 (https=)
JP2023503167A5 (https=)
AR040078A1 (es) Diaminotiazoles
JP2009515951A5 (https=)